0001493152-23-024969.txt : 20230719 0001493152-23-024969.hdr.sgml : 20230719 20230719210505 ACCESSION NUMBER: 0001493152-23-024969 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230717 FILED AS OF DATE: 20230719 DATE AS OF CHANGE: 20230719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grossman Fred CENTRAL INDEX KEY: 0001985154 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41583 FILM NUMBER: 231097940 MAIL ADDRESS: STREET 1: C/O COYA THERAPEUTICS, INC. STREET 2: 5850 SAN FELIPE ST., SUITE 500 CITY: HOUSTON STATE: TX ZIP: 77057 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Coya Therapeutics, Inc. CENTRAL INDEX KEY: 0001835022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12645 MEMORIAL DR., SUITE F1 #305 CITY: HOUSTON STATE: TX ZIP: 77024 BUSINESS PHONE: 650.739.3939 MAIL ADDRESS: STREET 1: 12645 MEMORIAL DR., SUITE F1 #305 CITY: HOUSTON STATE: TX ZIP: 77024 4 1 ownership.xml X0508 4 2023-07-17 0 0001835022 Coya Therapeutics, Inc. COYA 0001985154 Grossman Fred 5850 SAN FELIPE ST., SUITE 500 HOUSTON, TX 77057 0 1 0 0 Chief Medical Officer 0 Stock Option (right to buy) 4.25 2023-07-17 4 A 0 74069 A 2033-07-17 Common Stock, par value $0.0001 per share 74069 74069 D Subject to continuous service, 24,689 of the shares subject to the option will vest on July 17, 2024, and the remaining shares will vest in equal monthly installments over a period of 24 months commencing on August 17, 2024. /s/ David Snyder, Attorney-in-Fact 2023-07-19